This article ran on Monday, Feb. 23, 2026. On Wednesday, Feb. 25, 2026, Tandem announced the upsized pricing of the offering. Read the updated article here. Tandem Diabetes Care (Nasdaq:TNDM) announced today that it intends to offer $200 million in convertible senior notes, due in 2032. San Diego-based Tandem said it plans to offer […]
Wall Street Beat
ICU Medical resolves Smiths Medical warning letter, posts mixed Q4
ICU Medical (Nasdaq:ICUI) shares dipped slightly today on fourth-quarter results that were mixed compared to the consensus forecast. Shares of ICUI fell 1.25% to $149.74 apiece in early-morning trading today. The San Clemente, California-based infusion technology and critical care product provider reported losses of $15.7 million. That equals 64¢ per share on sales of $540.7 […]
Tandem stock rises on Q4 beats, new pay-as-you-go model
Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose 11.5% to $20.65 apiece after the market closed today. The San Diego-based automated insulin delivery technology developer reported losses of 589 million. That equals 1¢ per share on sales of $290.4 […]
Insulet stock rises before hours on Street-beating Q4, 31% sales growth
Insulet (Nasdaq:PODD) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of PODD ticked up more than 8% to $266.10 apiece in morning trading today. The Acton, Massachusetts–based automated insulin delivery technology developer reported profits of $101.6 million. That equals $1.44 per share on sales of $783.8 […]
Beta Bionics sales grow 57% in Street-beating Q4, guidance set for 2026
Beta Bionics (Nasdaq:BBNX) shares rose slightly after hours today on fourth-quarter results that topped the consensus forecast. Shares of BBNX ticked up about 1% to $14.10 apiece in post-market trading today. The Irvine, California-based automated insulin delivery system developer reported losses of $13.5 million. That equals 38¢ per share on sales of $32.1 million for […]
Medtronic submits MiniMed Flex to FDA, Diabetes separation is on track amid strong Q4
Medtronic (NYSE:MDT) said today that the separation of its MiniMed Diabetes unit remains on track as it advances the MiniMed Flex system. On the company’s third-quarter earnings call, CFO Thierry Piéton explained the business’ performance as it works toward completing an IPO — for which it filed at the end of 2025 — and bringing […]
Dexcom beats Street in Q4 on 13% sales growth
Dexcom (NSDQ:DXCM) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus forecast. Shares of DXCM rose 1% to $65.70 apiece in post-market trading today. The San Diego-based continuous glucose monitor (CGM) maker reported profits of $267.3 million. That equals 68¢ per share on sales of $1.259 billion for […]
Embecta stock ticks up on Street-beating Q1
Embecta (Nasdaq:EMBC) shares got a boost today on first-quarter results that beat the consensus Wall Street forecast. Shares of EMBC rose 6.5% to $12.09 apiece in early-morning trading today. The Parsippany, New Jersey-based BD Diabetes spinoff reported profits of $44.1 million. That equals 74¢ per share on sales of $261.2 million for the three months ended […]
Dexcom stock rises on Street-beating preliminary Q4 sales
Dexcom (NSDQ:DXCM) today announced preliminary fourth-quarter results that included revenues that topped the consensus forecast. For the quarter ended Dec. 31, 2025, the company expects total revenue of $1.26 billion. That marks a 13% increase over the same period a year ago and lands just ahead of expectations on Wall Street. Dexcom expects to report […]
Analysts downgrade Beta Bionics on new patient starts miss
Analysts downgraded Beta Bionics (Nasdaq:BBNX) to “Neutral” following preliminary fourth-quarter results that fell shy of expectations. Shares of BBNX fell 35% to $20.86 apiece in early-morning trading today. Beta Bionics, which has completed its first full year as a public company following its IPO last year, pre-announced fourth-quarter revenues of $32 million. That came in […]
